Lv3
344 积分 2022-07-28 加入
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancer
18天前
已完结
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
1个月前
已完结
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
1个月前
已完结
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer
2个月前
已完结
A Breakthrough From China in a Rare Form of Kidney Cancer
2个月前
已关闭
Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody–Drug Conjugates
3个月前
已完结
Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies
3个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
4个月前
已完结
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma
4个月前
已完结
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx Renal
4个月前
已完结
皖公网安备34019202002308
